(VIANEWS) – KBC (KBC.BR), NAVAMEDIC (NAVA.OL), MELHUS SPAREBANK (MELG.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. KBC (KBC.BR)
27.2% sales growth and 13.72% return on equity
KBC Group NV, together with its subsidiaries, provides integrated bank-insurance services primarily for retail, private banking, small and medium sized enterprises, and mid-cap clients. The company offers demand deposits and savings accounts; home and mortgage loans; consumer finance and SME funding services; credit, investment fund and asset management, and life and non-life insurance; and cash management, payments, trade finance, lease, money market, capital market products, and stockbroking services. It also provides digital and mobile banking services. The company was formerly known as KBC Bank and Insurance Holding Company NV and changed its name to KBC Group NV in March 2005. KBC Group NV was incorporated in 1935 and is headquartered in Brussels, Belgium.
Earnings Per Share
As for profitability, KBC has a trailing twelve months EPS of €7.43.
PE Ratio
KBC has a trailing twelve months price to earnings ratio of 8.97. Meaning, the purchaser of the share is investing €8.97 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.72%.
More news about KBC.
2. NAVAMEDIC (NAVA.OL)
22.8% sales growth and 22.97% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.73.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 21.04. Meaning, the purchaser of the share is investing kr21.04 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.97%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 93.3%, now sitting on 440.93M for the twelve trailing months.
Moving Average
NAVAMEDIC’s value is under its 50-day moving average of kr38.34 and above its 200-day moving average of kr36.12.
More news about NAVAMEDIC.
3. MELHUS SPAREBANK (MELG.OL)
16.5% sales growth and 8.79% return on equity
Melhus Sparebank, a savings bank, provides various banking products and services to companies, agriculture customers, and private individuals in Norway. The company offers savings accounts; construction and business loans; bank guarantee, overdraft, and leasing services; and credit and bank cards. It also provides various insurance products for liability, health, personnel, occupational injury, travel, accident, business, store, data attack, property damage, craftsman, homeowners, office, vehicle, and farms; savings and pension products; payment services; and online and mobile banking services. The company operates through branch offices in central Trondheim, Heimdal, Ler, and Korsvegen. Melhus Sparebank was founded in 1840 and is headquartered in Melhus, Norway.
Earnings Per Share
As for profitability, MELHUS SPAREBANK has a trailing twelve months EPS of kr13.62.
PE Ratio
MELHUS SPAREBANK has a trailing twelve months price to earnings ratio of 11.6. Meaning, the purchaser of the share is investing kr11.6 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.79%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Mar 17, 2023, the estimated forward annual dividend rate is 11 and the estimated forward annual dividend yield is 6.92%.
Volume
Today’s last reported volume for MELHUS SPAREBANK is 35 which is 88.05% below its average volume of 293.
Moving Average
MELHUS SPAREBANK’s value is below its 50-day moving average of kr158.58 and under its 200-day moving average of kr159.95.
Yearly Top and Bottom Value
MELHUS SPAREBANK’s stock is valued at kr158.00 at 02:20 EST, way under its 52-week high of kr177.00 and way higher than its 52-week low of kr142.00.
More news about MELHUS SPAREBANK.
4. PROTECTOR FORSIKRG (PROT.OL)
15.2% sales growth and 37.86% return on equity
Protector Forsikring ASA, a general insurance company, provides various insurance products to the commercial and public sectors, and the affinity insurance markets in Norway, Denmark, Sweden, the United Kingdom, and Finland. It operates in Commercial Lines of Business and Public Lines of Business segments. The company offers personal, motor, property, liability, and change of ownership insurance. It sells its products to non-marine industries through insurance brokers. Protector Forsikring ASA was founded in 2003 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, PROTECTOR FORSIKRG has a trailing twelve months EPS of kr15.19.
PE Ratio
PROTECTOR FORSIKRG has a trailing twelve months price to earnings ratio of 10.78. Meaning, the purchaser of the share is investing kr10.78 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 37.86%.
More news about PROTECTOR FORSIKRG.
5. MAREL (MAREL.AS)
5.5% sales growth and 4.51% return on equity
Marel hf. develops, distributes, and sells solutions, software, and services to food processing industries in Europe, the Middle East, Africa, the Americas, Asia, and Oceania. The company's Poultry Processing segment offers integrated systems, software, and services for processing broilers, turkeys, and ducks. Its Meat Processing segment supplies primary, secondary, and further processing equipment, systems, software, and services of pork, beef, veal, and sheep. The company's Fish Processing segment offers equipment, systems, software, and services for farmed and wild salmon and whitefish processing. Its Plant, pet and feed segment provides solutions and services to the pet food, plant-based protein, and aqua feed markets. Marel hf. was founded in 1977 and is based in Garðabær, Iceland.
Earnings Per Share
As for profitability, MAREL has a trailing twelve months EPS of €0.06.
PE Ratio
MAREL has a trailing twelve months price to earnings ratio of 50. Meaning, the purchaser of the share is investing €50 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.51%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Mar 24, 2023, the estimated forward annual dividend rate is 0.02 and the estimated forward annual dividend yield is 0.56%.
Volume
Today’s last reported volume for MAREL is 15006 which is 74.55% below its average volume of 58964.
Earnings Before Interest, Taxes, Depreciation, and Amortization
MAREL’s EBITDA is 80.54.
More news about MAREL.
